Time-varying association of Second Primary Malignancy and Long-term Survival Outcomes in Patients with Head and Neck Cancer.

A high risk of developing second primary malignancy (SPM) has been reported among head and neck cancer patients. Here, we aimed to statistically quantify the impact of SPM development on the survival of head and neck cancer patients. This study was conducted using the Surveillance, Epidemiology, and End Results database to collect the data of 48316 patients who received curative surgical resection for initial primary head and neck squamous cell carcinoma (IP-HNSCC) in 1975-2019. SPM diagnosis was treated as a time-varying covariate, and multivariable Cox regression analysis was conducted to estimate the association between SPM development and survival, overall or by the subsite of IP-HNSCC. Of the included patients, 11238 patients (23.3%) developed SPM during the follow-up period. A significant reduction in survival was observed among patients with SPM (hazard ratio [HR] for overall survival, 3.30; 95% confidence interval [CI]: 3.20-3.41). The impact of SPM development on reduced survival was more significant in patients with localized IP-HNSCC versus regional IP-HNSCC (HR OS , 3.41; 95% CI, 3.24-3.6 vs HR OS , 3.18; 95% CI, 3.05-3.31; p for interaction < 0.001). The survival impact of SPM development was more evident in younger patients than in older patients. SPM in lung and bronchus was associated with the most pronounced reduction in survival, overall and across all subsites of HNSCC. Our results indicated that SPM development led to a significant reduction in survival. A greater survival benefit may be achieved through intensive surveillance for SPM in lung and bronchus targeting younger patients and those with localized HNSCC. This article is protected by copyright. All rights reserved.